FDA Clearance Tracker · P180031-S012
Neuroform Atlas® Stent System
Last checked: Nov 20, 2026Latest source record: Oct 24, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Oct 24, 2026
Approved
Time to decision
234 days
Received Mar 4, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P180031-S012
- Device name
- Neuroform Atlas® Stent System
- Applicant
- Stryker Neurovascular
- Applicant location
- Fremont, CA
- Received
- Mar 4, 2026
- Decided
- Oct 24, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P180031
Device type
- Device type
- Intracranial coil-assist stent (QCA)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for a manufacturing site located at Nitinol Devices and Components Costa Rica, S.R.L., Building B28, El Coyol, Alajuela 20102 Costa Rica for the postlaser cutting operations of the Neuroform Atlas stent component
Source documents
Other decisions for Stryker Neurovascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261649 · Decided Oct 9, 2026 · 143 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.